184 related articles for article (PubMed ID: 30421066)
1. Patient Survival after Surgical Management in Intrathoracic Pseudomyxoma peritonei.
Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
Ann Surg Oncol; 2019 Jan; 26(1):238-243. PubMed ID: 30421066
[TBL] [Abstract][Full Text] [Related]
2. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.
Pestieau SR; Esquivel J; Sugarbaker PH
Ann Surg Oncol; 2000 Apr; 7(3):199-203. PubMed ID: 10791850
[TBL] [Abstract][Full Text] [Related]
3. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
4. Low-dose Pressurized Intrathoracic Aerosol Chemotherapy (PITAC) as an Alternative Therapy for Pleuropulmonary Involvement in Pseudomyxoma Peritonei.
Robella M; Vaira M; Borsano A; Mossetti C; DE Simone M
Anticancer Res; 2018 Feb; 38(2):929-932. PubMed ID: 29374723
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
Lu YY; Guo AT; Liu AJ; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
[TBL] [Abstract][Full Text] [Related]
6. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery plus bicavitary chemohyperthermia as treatment of pseudomixoma peritonei with pleural extension. A case report and review of the literature.
Saladino E; Famulari C; La Monaca E; Fortugno A; Fleres F; Macrì A
Ann Ital Chir; 2014; 85(4):372-6. PubMed ID: 25263588
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei.
Kawaguchi Y; Hanaoka J
Ann Thorac Surg; 2020 Dec; 110(6):e541-e543. PubMed ID: 32553770
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy.
Miner TJ; Shia J; Jaques DP; Klimstra DS; Brennan MF; Coit DG
Ann Surg; 2005 Feb; 241(2):300-8. PubMed ID: 15650641
[TBL] [Abstract][Full Text] [Related]
12. Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery.
Dohan A; Barral M; Eveno C; Lo Dico R; Kaci R; Pasteur-Rousseau A; Soyer P; Pocard M; Bonnin P
Eur J Surg Oncol; 2017 Oct; 43(10):1932-1938. PubMed ID: 28587731
[TBL] [Abstract][Full Text] [Related]
13. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach.
Gough DB; Donohue JH; Schutt AJ; Gonchoroff N; Goellner JR; Wilson TO; Naessens JM; O'Brien PC; van Heerden JA
Ann Surg; 1994 Feb; 219(2):112-9. PubMed ID: 8129481
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the appendix with extra-appendicular spread: Clinico-surgical and histologic analysis of 27 cases.
Morera Ocón FJ; Camps Vilata B; Muñoz Forner E; Navarro Campoy C; Gallego Plazas J; Navarro Fos S
Med Clin (Barc); 2017 Aug; 149(4):153-156. PubMed ID: 28549831
[TBL] [Abstract][Full Text] [Related]
16. Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma.
Proesmans V; Vandaele T; Van Slambrouck J; Wolthuis A; D Hoore A; Dekervel J; Van Cutsem E; Dresen R; De Hertogh G; Degezelle K; Van Raemdonck D; Nafteux P; Ceulemans LJ
Int J Hyperthermia; 2022; 39(1):1153-1157. PubMed ID: 36049823
[No Abstract] [Full Text] [Related]
17. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
Saxena A; Yan TD; Chua TC; Morris DL
Ann Surg Oncol; 2010 May; 17(5):1291-301. PubMed ID: 20039212
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
[TBL] [Abstract][Full Text] [Related]
19. Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery.
Hotta M; Minamimoto R; Gohda Y; Tajima T; Kiyomatsu T; Yano H
Eur Radiol; 2020 Aug; 30(8):4193-4200. PubMed ID: 32211961
[TBL] [Abstract][Full Text] [Related]
20. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]